Transcenta

About:

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture.

Website: http://www.transcenta.com/

Top Investors: Temasek Holdings, Sequoia Capital, ARCH Venture Partners, Hillhouse Investment, Fortune Venture Capital

Description:

Transcenta is a global biotherapeutic company that fully integrates antibody-based biotherapeutics discovery, R&D and manufacture, focusing on developing innovative antibodies to help more patients. HJB and MabSpace Biosciences merged and created Transcenta.

Total Funding Amount:

$342M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Huangpu, Shanghai, China

Founded Date:

2019-01-01

Contact Email:

media(AT)transcenta.com

Founders:

Jonathan Zhao, Xueming Qian, Yining Zhao

Number of Employees:

101-250

Last Funding Date:

2021-11-29

IPO Status:

Public

Industries:

Biopharma

Biotechnology

© 2025 bioDAO.ai